The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice (Abstract)

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice Front Pharmacol 19 June 2019 https://pubmed.ncbi.nlm.nih.gov/31275146/ Breast cancer with bone metastasis is essentially incurable with current anticancer therapies. The bone morphogenetic protein (BMP) pathway is an attractive therapeutic candidate, as it is involved in the bone turnover and in cancer cell formation and […]

Susie – Wales: Breast Cancer, Multiple Sclerosis (MS) (LDN, low dose naltrexone)

Susie – Wales: Breast Cancer, Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. With hindsight, Susie realises that she started to get symptoms after a bout of Glandular Fever and a Hepatitis B injection. She didn’t really think she needed to address her symptoms until after her daughter was born […]